Fadeev, Roman <br/><br/>
Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD.  [electronic resource] 

 -  International journal of molecular sciences  Jan 2019 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1422-0067 
<br/><br/><label>Standard No.: </label>10.3390/ijms20030525  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Fibrosarcoma--drug therapy<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Oligopeptides--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Sorafenib--administration & dosage<br/>TNF-Related Apoptosis-Inducing Ligand--genetics<br/>Xenograft Model Antitumor Assays